193
Views
12
CrossRef citations to date
0
Altmetric
Original Article

Costs of skin and skin structure infections due to Staphylococcus aureus: an analysis of managed- care claims*

, , , , &
Pages 2821-2828 | Accepted 24 Jul 2008, Published online: 28 Aug 2008

References

  • Nichols RL. Optimal treatment of complicated skin and skin structure infections. J Antimicrob Chemother 1999;44 (Suppl A):19-23
  • Martone WJ, Nichols RL. Recognition, prevention, surveillance, and management of surgical site infections: introduction to the problem and symposium overview. Clin Infect Dis 2001; 33 (Suppl 2):S67-S68
  • McCaig LF, McDonald LC, Mandal S,. et al. Staphylococcus aureus-associated skin and soft tissue infections in ambulatory care. Emerg Infect Dis. 2006;12:715-23
  • Chambers HF. The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis. 2001;7:178-82
  • Division of Healthcare Quality Promotion, National center for Infectious Diseases, Centers for Disease Control and Prevention (CDC), US Department of Health and Human Services. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004;32:470-85
  • Ploy MC, Grelaud C, Martin C,. et al. First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital. Lancet 1998;351:1212
  • Fung HB, Chang JY, Kuczynski S. A practical guide to the treatment of complicated skin and soft tissue infections. Drugs 2003; 63:1459-80
  • Panlilio AL, Culver DH, Gaynes RP,. et al. Methicillin-resistant Staphylococcus aureus in US hospitals, 1975–1991. Infect Control Hospital Epidemiol 1992;13:582-6
  • Marton JP, Menzin J, Sussman M,. et al. The clinical and economic burden of complicated skin and skin structure infections due to Staphylococcus aureus: findings from a national database. Value in Health 2007;10:A165-A166
  • McKinnon PS, Carter C, Girase MS,. et al. The economic effect of oral linezolid versus intravenous vancomycin in the outpatient setting: the payer perspective. Managed Care Interface. 2007;20:23-34
  • Lew DP, Waldvogel FA. Osteomyelitis. New Engl J Med 1997; 336:999-1009
  • Charlson ME, Pompei P, Ales KL,. et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83
  • Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.